Semaglutide stimulates GLP-1 receptors to increase insulin secretion in response to meals, suppress glucagon, and slow gastric emptying, while tirzepatide adds GIP receptor action that further reduces appetite and body weight
See Instructions for Use for more information
1 If you have Medicare Part B primary, your costs for prescription drugs may be lower
Exposure to benzo(a)pyrene from juvenile period to peripubertal impairs male reproductive parameters in adult rats
The shelf life in the fridge depends on proper storage from the moment of manufacture through delivery to your home
Semaglutide (Ozempic, Wegovy) targets GLP-1, which controls blood glucose, decreases appetite, and slows digestion to normalize hunger